Drug-resistant bacterial pathogens represent a significant threat to public health, and a complicated assortment of factors has combined to stymie antibiotic development and fuel this growing crisis.1,2 The current situation has prompted a need for renewed discovery and development of novel antibacterials; however experience has shown that conventional chemotherapies are inevitably undermined by rapid evolution of their target organisms.3 Therefore, to more comprehensively address this threat, conventional antibiotic discovery and development strategies need to be complemented by searches within previously untapped molecular reservoirs.